Tacoma, WA, United States of America

Chris Alan Causey

This inventor holds 2 USPTO granted patents. Top assignees: Oregon State University, Bluetapp, Inc., Blutapp, Inc.. Active years: 2020-2026.


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chris Alan Causey: Innovator in Therapeutic Technology

Introduction

Chris Alan Causey is a notable inventor based in Tacoma, WA (US). He has made significant contributions to the field of therapeutic technology, particularly through his innovative patent. His work focuses on enhancing therapeutic methods using modern technology.

Latest Patents

Chris Alan Causey holds a patent for a "Remotely controlled bilateral alternating tactile stimulation therapeutic method and system." This system includes an Internet web page and two mobile devices that communicate with each other. The first mobile device transmits audio and pulse control information, while the second device receives this information in real-time. The system is designed to enable users to experience therapeutic benefits through alternating tactile stimulation.

Career Highlights

Throughout his career, Chris has worked with reputable organizations such as Oregon State University and Bluetapp, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas. His dedication to advancing therapeutic technology is evident in his work and contributions.

Collaborations

Chris has collaborated with Dakota Pellegrino, further enhancing his projects and expanding his reach in the field of therapeutic technology.

Conclusion

Chris Alan Causey is a pioneering inventor whose work in therapeutic technology has the potential to improve the lives of many. His innovative patent and career achievements reflect his commitment to advancing the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…